Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Concomitant Use of Panobinostat and Reirradiation in Progressive DIPG: Report of 2 Cases
View through CrossRef
Diffuse intrinsic pontine glioma (DIPG) remains a devastating disease. Panobinostat has been shown to have therapeutic efficacy both in vitro and in DIPG orthotopic xenograft models; however, clinical data in patients with DIPG are lacking. We present 2 cases of DIPG, who were treated with panobinostat at 22 to 25 mg/m2/dose, 3 times weekly for 2 weeks in 3-week cycles and concomitant reirradiation after disease progression. Two episodes of asymptomatic thrombocytopenia were observed in 1 patient. Hyperacetylation of histone H4 of peripheral blood mononuclear cells was evident following treatment. In our experience, panobinostat administered with reirradiation was well tolerated at a relatively higher dose than that used in adult studies.
Ovid Technologies (Wolters Kluwer Health)
Title: Concomitant Use of Panobinostat and Reirradiation in Progressive DIPG: Report of 2 Cases
Description:
Diffuse intrinsic pontine glioma (DIPG) remains a devastating disease.
Panobinostat has been shown to have therapeutic efficacy both in vitro and in DIPG orthotopic xenograft models; however, clinical data in patients with DIPG are lacking.
We present 2 cases of DIPG, who were treated with panobinostat at 22 to 25 mg/m2/dose, 3 times weekly for 2 weeks in 3-week cycles and concomitant reirradiation after disease progression.
Two episodes of asymptomatic thrombocytopenia were observed in 1 patient.
Hyperacetylation of histone H4 of peripheral blood mononuclear cells was evident following treatment.
In our experience, panobinostat administered with reirradiation was well tolerated at a relatively higher dose than that used in adult studies.
Related Results
DIPG-01. REIRRADIATION PRACTICES FOR DIFFUSE INTRINSIC PONTINE GLIOMA
DIPG-01. REIRRADIATION PRACTICES FOR DIFFUSE INTRINSIC PONTINE GLIOMA
Abstract
INTRODUCTION
Diffuse intrinsic pontine gliomas (DIPG) are a leading cause of brain tumor deaths in children. Current st...
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct
Introduction
Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Panobinostat Inhibits JAK2/STAT3 Pathway in Multiple Myeloma.
Panobinostat Inhibits JAK2/STAT3 Pathway in Multiple Myeloma.
Abstract
Abstract 2849
Poster Board II-825
Histone deacetylase inhibitors (HDACi) are emerging as a potential therapy for Multiple Myel...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Synergistic Effect of Panobinostat and Bortezomib on Chemoresistant Acute Myelogenous Leukemia Cells Via Akt/NF-κB Pathway,
Synergistic Effect of Panobinostat and Bortezomib on Chemoresistant Acute Myelogenous Leukemia Cells Via Akt/NF-κB Pathway,
Abstract
Abstract 3621
Introduction:
The mechanism of MDR (multiple drug resistance) in acute myelogenous leukemi...
Abstract 900: Dianhydrogalactitol (VAL-083) has the potential to overcome major challenges in the treatment of DIPG
Abstract 900: Dianhydrogalactitol (VAL-083) has the potential to overcome major challenges in the treatment of DIPG
Abstract
Despite decades of clinical trials, children with diffuse intrinsic pontine gliomas (DIPG) continue to have a very poor prognosis and dismal survival. DIPG ...
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Abstract 5870: Epigenetic drug treatment overcomes osteoblast-induced chemoprotection by suppressing cell adhesion and related signaling
Abstract 5870: Epigenetic drug treatment overcomes osteoblast-induced chemoprotection by suppressing cell adhesion and related signaling
Abstract
Acute lymphoblastic leukemia (ALL) is the most commonly diagnosed cancer in pediatric patients. Recent advances have allowed for improved efficacy of treatm...